Although it was reported that CA19‐9 concentration is superior to CEA in judging the necessity of surgical removal of advanced gallbladder cancer,16 as well as in prediction of disease progression of GBC patients,17, 18 our result showed that CEA showed an advantage in differentiating GBC and XGC. The gene discussed is CEACAM5; the disease is gallbladder cancer.